{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:25:21Z","timestamp":1783196721582,"version":"3.54.6"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,12,30]],"date-time":"2005-12-30T00:00:00Z","timestamp":1135900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>The identification of predictors for prostate biopsy outcome at two screening rounds using a PSA \u22653.0 ng\/ml as biopsy indication.<\/jats:p><\/jats:sec><jats:sec><jats:title>MATERIALS AND METHODS<\/jats:title><jats:p>We compared predictors by means of descriptive statistics and logistic regression analysis in men (55\u201375 years) biopsied in either the 1st or 2nd screening round of ERSPC Rotterdam (interval 4 years).<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Positive predictors for biopsy outcome in both screening rounds were an increased PSA level in the absence of a previous negative biopsy (PrevNB), DRE and TRUS suspicious and a positive family history (PFH). A higher than median prostate volume was a consistent negative predictor. Having had a PrevNB at initial screening strongly reduced the chance of cancer detection at repeat screening and in addition canceled the predictive potential of PSA.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>If \u201cdetecting prostate cancer efficiently\u201d were the aim, this study indicates that a \u201cPSA only based biopsy threshold\u201d may be replaced by another criterion incorporating, e.g., DRE, TRUS and prostate volume in men who were biopsied in the preceding 4 year interval. Prostate 66:604\u2013612, 2006. \u00a9 2005 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pros.20352","type":"journal-article","created":{"date-parts":[[2005,12,30]],"date-time":"2005-12-30T14:17:19Z","timestamp":1135952239000},"page":"604-612","source":"Crossref","is-referenced-by-count":39,"title":["A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55\u201375 years using a biopsy indication of 3.0 ng\/ml (results of ERSPC, Rotterdam)"],"prefix":"10.1002","volume":"66","author":[{"given":"Monique J.","family":"Roobol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz H.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ries","family":"Kranse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,30]]},"reference":[{"issue":"2","key":"e_1_2_1_2_2","first-page":"1","article-title":"European randomized study of screening for prostate cancer: Rationale, structure and preliminary results 1994\u20132003","volume":"92","author":"Roobol MJ","year":"2003","journal-title":"BJU Int"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2003.04390.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2001.1256_1.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg057"},{"key":"e_1_2_1_6_2","volume-title":"Nutrition and cancer","author":"Griffiths K","year":"1996"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480160073037"},{"issue":"4","key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0094-0143(21)00919-8","article-title":"PSA velocity for the diagnosis of early prostate cancer. A new concept","volume":"20","author":"Carter HB","year":"1993","journal-title":"Urol Clin North Am"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)01646-1"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20840"},{"issue":"12","key":"e_1_2_1_11_2","first-page":"3323","article-title":"Estimation of prostatic growth using serial prostate\u2010specific antigen measurements in men with and without prostate disease","volume":"52","author":"Carter HB","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.12.868"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11668"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.20352","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.20352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:08:09Z","timestamp":1700078889000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.20352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,30]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1002\/pros.20352"],"URL":"https:\/\/doi.org\/10.1002\/pros.20352","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,30]]}}}